| An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 R Koczulla, G Von Degenfeld, C Kupatt, F Krötz, S Zahler, T Gloe, ... The Journal of clinical investigation 111 (11), 1665-1672, 2003 | 1110 | 2003 |
| Biology and clinical relevance of naturally occurring antimicrobial peptides RL Gallo, M Murakami, T Ohtake, M Zaiou Journal of Allergy and Clinical Immunology 110 (6), 823-831, 2002 | 412 | 2002 |
| Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence M Zaiou, V Nizet, RL Gallo Journal of Investigative Dermatology 120 (5), 810-816, 2003 | 351 | 2003 |
| Multifunctional antimicrobial peptides: therapeutic targets in several human diseases M Zaiou Journal of Molecular Medicine 85, 317-329, 2007 | 313 | 2007 |
| Cathelicidins, essential gene-encoded mammalian antibiotics M Zaiou, RL Gallo Journal of molecular medicine 80, 549-561, 2002 | 304 | 2002 |
| Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid KL Gillotte, M Zaiou, S Lund-Katz, GM Anantharamaiah, P Holvoet, ... Journal of Biological Chemistry 274 (4), 2021-2028, 1999 | 224 | 1999 |
| Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens MH Braff, M Zaiou, J Fierer, V Nizet, RL Gallo Infection and immunity 73 (10), 6771-6781, 2005 | 221 | 2005 |
| IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort N Haddy, C Sass, S Droesch, M Zaiou, G Siest, A Ponthieux, D Lambert, ... Atherosclerosis 170 (2), 277-283, 2003 | 210 | 2003 |
| Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection PHA Lee, T Ohtake, M Zaiou, M Murakami, JA Rudisill, KH Lin, RL Gallo Proceedings of the National Academy of Sciences 102 (10), 3750-3755, 2005 | 183 | 2005 |
| Genetic determinants of blood pressure regulation JB Marteau, M Zaiou, G Siest, S Visvikis-Siest Journal of hypertension 23 (12), 2127-2143, 2005 | 152 | 2005 |
| Apolipoprotein E–low density lipoprotein receptor interaction: influences of basic residue and amphipathic α-helix organization in the ligand M Zaiou, KS Arnold, YM Newhouse, TL Innerarity, KH Weisgraber, ... Journal of Lipid Research 41 (7), 1087-1095, 2000 | 102 | 2000 |
| The clinical potential of adipogenesis and obesity-related microRNAs M Zaiou, H El Amri, A Bakillah Nutrition, Metabolism and Cardiovascular Diseases 28 (2), 91-111, 2018 | 101 | 2018 |
| Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism P Acharya, ML Segall, M Zaiou, J Morrow, KH Weisgraber, MC Phillips, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2002 | 94 | 2002 |
| circRNAs signature as potential diagnostic and prognostic biomarker for diabetes mellitus and related cardiovascular complications M Zaiou Cells 9 (3), 659, 2020 | 72 | 2020 |
| Effects of lipid interaction on the lysine microenvironments in apolipoprotein E S Lund-Katz, M Zaiou, S Wehrli, P Dhanasekaran, F Baldwin, ... Journal of Biological Chemistry 275 (44), 34459-34464, 2000 | 69 | 2000 |
| Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE S Lund-Katz, S Wehrli, M Zaiou, Y Newhouse, KH Weisgraber, ... Journal of Lipid Research 42 (6), 894-901, 2001 | 55 | 2001 |
| Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors H Benachour, M Zaiou, A Samara, B Herbeth, M Pfister, D Lambert, ... Nutrition, Metabolism and Cardiovascular Diseases 19 (10), 720-728, 2009 | 45 | 2009 |
| Cardiovascular pharmacogenetics: a promise for genomically‐guided therapy and personalized medicine M Zaiou, H El Amri Clinical genetics 91 (3), 355-370, 2017 | 44 | 2017 |
| DNA polymorphisms of human apolipoprotein A‐IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population M Zaiou, S Visvikis, R Gueguen, HJ Parra, JC Fruchart, G Siest Clinical genetics 46 (3), 248-254, 1994 | 37 | 1994 |
| Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases M Zaiou Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders …, 2019 | 35 | 2019 |
